Boundless Bio
demonstrated synthetic lethality in combination with kras inhibition in kras addicted cancer both preventing and treating resistance post emergence | Boundless Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
41 of 51
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io